Oricula
is a biotechnology company that develops and commercializes drugs to prevent hearing loss... Read moreOricula
is a biotechnology company that develops and commercializes drugs to prevent hearing loss... Read more
News
Sep 27, 2018
BioPortfolio
Oricula: Decibel Therapeutics and Oricula Therapeutics Announce Exclusive License for ORC13661 in Phase 1 Development for Hearing and Balance Protection
Feb 05, 2018
WardsAuto
Oricula: FDA Clears Oricula Therapeutics Investigational New Drug Application for Clinical Trials
Feb 02, 2016
BioSpace
Oricula: Oricula Therapeutics Secures $2M NIH Grant To Further Develop Medicine To Preserve Hearing
May 01, 2014
PHARMACEUTICAL BUSINESS REVIEW
Oricula: Oricula Therapeutics secures NIH grant to further develop medicine to preserve hearing
Apr 30, 2014
BIOSPACE
Oricula: Oricula Therapeutics Secures National Institutes of Health (NIH) Grant To Further Develop Medicine To Preserve Hearing
Apr 11, 2014
PHARMACEUTICAL BUSINESS REVIEW
Oricula: Oricula Therapeutics secures initial funding from University of Washington
Apr 09, 2014
GEEKWIRE
Oricula: UW spin-out Oricula Therapeutics raises cash to sell medicine that prevents hearing loss
Apr 09, 2014
PR NEWSWIRE
Press Release: Oricula : Oricula Therapeutics Secures Intellectual Property and Takes First Step to Commercialize Medicine to Preserve Hearing Licensing Agreement with University of Washington
Oricula Competitors
1
2
3
4
5
6
7
8
9
10